Challenges in Managing Oral Manifestations of Anticonvulsant-Induced Drug Reaction with Eosinophilia and Systemic Symptoms Syndrome

Fildzah Nurul Fajrin  -  Oral Medicine Program Residency, Faculty Of Dentistry, Universitas Indonesia, Indonesia
Indriasti Indah Wardhany*  -  Oral Medicine Department, Faculty of Dentistry, Universitas Indonesia; Dental and Oro-maxillofacial Unit, Universitas Indonesia Hospital, Indonesia
Febrina Rahmayanti  -  Oral Medicine Department, Faculty of Dentistry, Universitas Indonesia; Dental and Oro-maxillofacial Unit, Universitas Indonesia Hospital, Indonesia
Muhammad Ikhsan  -  Internal Medicine Unit, Universitas Indonesia Hospital, Indonesia
David Pangeran  -  Neurology Unit, Universitas Indonesia Hospital, Indonesia

(*) Corresponding Author

Background : Antiepileptic drugs were common causative agents for DRESS syndrome, which was a severe, idiosyncratic drug hypersensitivity reaction characterized by a prolonged latency period, fever, rash, and marked eosinophilia. The oral manifestations present a diagnostic challenge due its similarity to other hypersensitivity reactions as well as its comprehensive management. Objective: This case report aims to describe the challenges in comprehensive management of DRESS syndrome severe oral manifestations, highlighting the  challenges from diagnosis to management for patient with complex comorbidities. Case: A 19-year-old female inpatient was referred to Oral Medicine division, Dental and Oro-maxillofacial unit of Universitas Indonesia Hospital  (RSUI) for severe oral sores after treated with phenytoin and lamotrigine for her temporal lobe epilepsy and bipolar affective disorder. Patient shows general weakness and clinical examination revealed multiple intra oral erosions, lips erosions with exfoliation and haemorrhagic crust, generalized maculopapular rash, facial oedema, tender lymphadenopathy, and. Laboratory findings confirmed a severe hyper-eosinophilia (32%) and lymphopenia (13.5%), while liver function was normal. A diagnosis of DRESS syndrome was finally established. Case management were immediate withdrawal of phenytoin and lamotrigine, followed by multidisciplinary care including intra vena and topical corticosteroids. The patient's condition significantly improved after collaborative comprehensive treatment. Conclusion: Definitive diagnosis decisions requires careful consideration on the correlation of clinical findings, medication history, and hallmark laboratory results, especially in patients with complex comorbidities and intraoral clinical features with characteristics similar to other hypersensitivity reactions. Comprehensive collaborative management, including patient’s and other healthcare professionals collaboration, is crucial for successful treatment.

Keywords: DRESS Syndrome; oral manifestation; phenytoin; lamotrigine; temporal lobe epilepsy; affective bipolar

  1. Chen CB, Hung WK, Wang CW, Lee CC, Hung SI, Chung WH. Advances in understanding of the pathogenesis and therapeutic implications of drug reaction with eosinophilia and systemic symptoms: an updated review. Front Med. 2023 June 29;10:1187937.
  2. Husain Z, Reddy BY, Schwartz RA. DRESS syndrome. J Am Acad Dermatol. 2013 May;68(5):693.e1-693.e14.
  3. Ochando Díez-Canseco M, Reguero Capilla M, Domínguez-Romero I, Menéndez-Rivero E, Prados-Castaño M. DRESS syndrome and flare-up due to antiepileptics: how to solve the problem. Neurol Engl Ed. 2025 May;40(4):406–8.
  4. De A, Rajagopalan M, Sarda A, Das S, Biswas P. Drug reaction with eosinophilia and systemic symptoms: An update and review of recent literature. Indian J Dermatol. 2018;63(1):30.
  5. Maverakis E, Ji‐Xu A, Brüggen M. Targeting interleukin‐5 with benralizumab: A novel treatment for drug rash with eosinophilia and systemic symptoms. Allergy. 2022 Aug;77(8):2287–9.
  6. Koomdee N, Pratoomwun J, Jantararoungtong T, Theeramoke V, Tassaneeyakul W, Klaewsongkram J, et al. Association of HLA-A and HLA-B Alleles with Lamotrigine-Induced Cutaneous Adverse Drug Reactions in the Thai Population. Front Pharmacol. 2017 Nov 29;8:879.
  7. Rashid M, Rajan AK, Chhabra M, Kashyap A, Chandran VP, Venkataraman R, et al. Role of human leukocyte antigen in anti-epileptic drugs-induced Stevens–Johnson Syndrome/toxic epidermal necrolysis: A meta-analysis. Seizure Eur J Epilepsy. 2022 Nov;102:36–50.
  8. Anci E, Braun C, Marinosci A, Rodieux F, Midun E, Torres MJ, et al. Viral Infections and Cutaneous Drug-Related Eruptions. Front Pharmacol. 2021 Mar 10;11:586407.
  9. Samim F, Auluck A, Zed C, Williams PM. Erythema Multiforme. Dent Clin North Am. 2013 Oct;57(4):583–96.
  10. Taweesedt PT, Nordstrom CW, Stoeckel J, Dumic I. Pulmonary Manifestations of Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) Syndrome: A Systematic Review. BioMed Res Int. 2019 Sept 24;2019:1–10.
  11. Choudhary S, McLEOD M, Torchia D, Romanelli P. Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) Syndrome. 2013;6(6).
  12. Rama MCR, Bindhu Madhavi G, Mohan A, Prakash RB, Devi BV. Drug rash with eosinophilia and systemic symptoms (DRESS): A report of two cases. J Clin Sci Res. 2023 Oct;12(Suppl 2):S111–4.
  13. Ben Salha W, Moussaoui E, Oualha L, Anoun J, Douki N. Erosive cheilitis as an early manifestation in DRESS syndrome. Clin Case Rep. 2021 Nov;9(11):e05123.
  14. Hambly JL, Haywood A, Hattingh L, Nair RG. Comparison between self‐formulation and compounded‐formulation dexamethasone mouth rinse for oral lichen planus: a pilot, randomized, cross‐over trial. J Investig Clin Dent. 2017 Aug;8(3):e12225.
  15. Ramadas A, Jose R, Arathy S, Kurup S, Chandy M, Kumar S. Systemic absorption of 0.1% triamcinolone acetonide as topical application in management of oral lichen planus. Indian J Dent Res. 2016;27(3):230.
  16. Taléns-Visconti R, Perra M, Ruiz-Saurí A, Nácher A. New Vehiculation Systems of Mometasone Furoate for the Treatment of Inflammatory Skin Diseases. Pharmaceutics. 2022 Nov 22;14(12):2558.
  17. Thongprasom K. A Review of the Effectiveness and Side-Effects of Fluocinolone Acetonide 0.1% in the Treatment of Oral Mucosal Diseases. Acta Stomatol Croat. 2017 Sept 15;51(3):240–7.
  18. Systemic Versus Topical Corticosteroids in the Treatment of DRESS_ A Retrospective Cohort Study Followed by a Meta-Analysis _ American Journal of Clinical Dermatology.
  19. Lopes JP, Lionakis MS. Pathogenesis and virulence of Candida albicans. Virulence. 2022 Dec 31;13(1):89–121.
  20. Faculty of Dental Medicine, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania, Nuncă AM, Coculescu EC, Faculty of Dental Medicine, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania, Coculescu BI, 1.Faculty of Midwifery and Nursing, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania2.Cantacuzino National Military Medical Institute for Research and Development, Bucharest, Romania. THE ROLE OF GENERAL FACTORS IN THE PATHOGENESISOF ORAL CANDIDIASIS. Romanian Arch Microbiol Immunol. 2022 Dec 30;81(4):271–7.

Lisensi Creative Commons
This work is licensed under a Lisensi Creative Commons Atribusi-BerbagiSerupa 4.0 Internasional.
Contact us: Odonto Dental Journal: Jl. Raya Kaligawe Km.4, PO BOX 1054/SM Semarang, Central Java, Indonesia, 50112. Email: odontodentaljournal@unissula.ac.id
apps